Wegovy 2.4mg Pen (9.6mg TOTAL) [Semaglutide Injection] (3.2mg/mL) – 4 Doses of 2.4mg | CANADIAN PHARMACEUTICAL GRADE

$400.00

In stock

WEGOVY 2.4MG/DOSE PREFILLED PEN – CANADIAN PHARMACEUTICAL GRADE SEMAGLUTIDE INJECTION

Wegovy (Semaglutide) 2.4mg/dose is a Canadian pharmaceutical grade GLP-1 receptor agonist provided in a prefilled injectable pen for precise, single-dose administration. It is widely used in research to study metabolic regulation, glucose homeostasis, and energy balance pathways.

This high-quality formulation delivers consistent dosage accuracy and stability for long-term experimental use, allowing researchers to evaluate the physiological effects of GLP-1 receptor activation on metabolic and appetite-related mechanisms.

The Details:

  • Dosage: 2.4mg semaglutide per dose

  • Form: Prefilled injection pen

  • Quantity: Single-use pen, ready for controlled application

  • Packaging: Sterile, tamper-evident pen in sealed packaging

  • Source: Canadian pharmaceutical grade, third-party tested for purity and consistency

Key Features of Wegovy 2.4mg:

  • Metabolic Regulation Research: Supports studies on energy homeostasis and glucose signaling.

  • GLP-1 Pathway Analysis: Enables examination of incretin-related receptor pathways.

  • Dose Precision: Prefilled delivery system ensures reliable and reproducible dosing.

  • Appetite and Energy Studies: Investigated for effects on satiety and caloric intake regulation.

  • Pharmaceutical Authenticity: Canadian-produced and independently verified.

For more products, visit: https://www.canadasteroiddepot.is/

WEGOVY 2.4MG/DOSE PREFILLED PEN – CANADIAN PHARMACEUTICAL GRADE SEMAGLUTIDE INJECTION

Wegovy (Semaglutide) 2.4mg/dose is a Canadian pharmaceutical grade GLP-1 receptor agonist provided in a prefilled injectable pen for precise, single-dose administration. It is widely used in research to study metabolic regulation, glucose homeostasis, and energy balance pathways.

This high-quality formulation delivers consistent dosage accuracy and stability for long-term experimental use, allowing researchers to evaluate the physiological effects of GLP-1 receptor activation on metabolic and appetite-related mechanisms.

The Details:

  • Dosage: 2.4mg semaglutide per dose

  • Form: Prefilled injection pen

  • Quantity: Single-use pen, ready for controlled application

  • Packaging: Sterile, tamper-evident pen in sealed packaging

  • Source: Canadian pharmaceutical grade, third-party tested for purity and consistency

Key Features of Wegovy 2.4mg:

  • Metabolic Regulation Research: Supports studies on energy homeostasis and glucose signaling.

  • GLP-1 Pathway Analysis: Enables examination of incretin-related receptor pathways.

  • Dose Precision: Prefilled delivery system ensures reliable and reproducible dosing.

  • Appetite and Energy Studies: Investigated for effects on satiety and caloric intake regulation.

  • Pharmaceutical Authenticity: Canadian-produced and independently verified.

For more products, visit: https://www.canadasteroiddepot.is/

Main Menu

Wegovy 2.4mg Pen (9.6mg TOTAL) [Semaglutide Injection] (3.2mg/mL) - 4 Doses of 2.4mg | CANADIAN PHARMACEUTICAL GRADE

Wegovy 2.4mg Pen (9.6mg TOTAL) [Semaglutide Injection] (3.2mg/mL) - 4 Doses of 2.4mg | CANADIAN PHARMACEUTICAL GRADE